UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Mill Creek Capital Advisors LLC

Mill Creek Capital Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 77.4% in the fourth quarter, HoldingsChannel reports. The fund owned 2,971 shares of the healthcare conglomerate’s stock after purchasing an additional 1,296 shares during the quarter. Mill Creek Capital Advisors LLC’s holdings in UnitedHealth Group were worth $1,503,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. M&T Bank Corp lifted its stake in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after acquiring an additional 1,193 shares during the period. Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $21,165,000. Finally, Signal Advisors Wealth LLC raised its holdings in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. UBS Group cut their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Up 1.2 %

Shares of UNH stock opened at $533.17 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $490.66 billion, a P/E ratio of 34.40, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a 50-day moving average price of $529.18 and a 200 day moving average price of $564.40.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.